Proximal Ventures raises debut fund to back startups bringing AI to drug development
Summary
Sahir Raoof has launched a new investment vehicle with $27.5 million in capital. The venture fund will focus on supporting early-stage companies that integrate artificial intelligence into pharmaceutical research and drug creation.
Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma
Source: Read the full story at TechCrunch
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.